Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 Amendment to Articles of Incorporation of the Company Related to the Name Change
- 3.2 Certificate of Designation of Preferences, Rights and Limitations of Series C-1 Preferred Stock
- 10.4 Placement Agency Agreement, Dated As of June 24, 2020, by and Among Delmar Pharmaceuticals, Inc. and Aegis Capital Corp
- 10.5 Form of Subscription Agreement
- 99.1 Press Release Dated August 18, 2020
- 99.2 Press Release Dated August 20, 2020
- 99.3 Press Release Dated August 21, 2020
HURA similar filings
- 1 Sep 20 Kintara Therapeutics Completes Final Closing of Previously Announced Private Placement For an Aggregate of $25 Million
- 25 Aug 20 Kintara Therapeutics Announces Additional $2.4 Million Private Placement Priced At-The-Market
- 24 Aug 20 Independent Auditor’s Report
- 21 Aug 20 DelMar Announces $19.6 Million Private Placement Priced At-The-Market
- 17 Aug 20 DelMar Announces Approval of Merger by Stockholders
- 26 Jun 20 Submission of Matters to a Vote of Security Holders
- 24 Jun 20 Other Events
Filing view
External links
